CCRB Logo

Trial History Detail on 2011-02-08

CUHK_CCT00169

2008-10-14

Prospective

nil

Direct grant (faculty of medicine)

Nil

Nil

Lee Chui Ping

Rm 622B, 6/F, Li Choh Ming BMSB, CUHK

26096819

cplee@cuhk.edu.hk

School of Pharmacy, CUHK

Lee Chui Ping

Rm 622B, 6/F, Li Choh Ming BMSB, CUHK

26096819

cplee@cuhk.edu.hk

School of Pharmacy, CUHK

Impact of an Interdisciplinary Approach on Symptom Management of Newly Diagnosed Depressive Patients

Impact of an Interdisciplinary Approach on Symptom Management of Newly Diagnosed Depressive Patients

nil

Hong Kong, China

Yes

2008-07-04

Depression

Other

patient education

Pharmacist education

6 months

Patients in control group will be provided with one educational leaflet in the initial visit (i.e. the same educational leaflet received by patients in IG) and will receive usual care in the outpatient psychiatry clinic. A trained, non-pharmacist personnel will meet with the patient to provide contact time comparable to that of the patients in the intervention group.

Adult patients, who are newly diagnosed with depressive disorders, able to communicate in Cantonese or English, have no previous exposure (within the past six months) to any antidepressants, and will start a treatment with an antidepressant, will be included.   

Exclusion: have dementia or any kinds of significant cognitive impairment, hearing impairment, terminal illnesses, psychosis, bipolar disorder, history of alcohol or any kinds of substance abuse, 2. have high suicidal risks, and 3. are pregnant or nursing, illiterate, taking St John's Wort or any other Traditional Chinese Medicines (TCM) for depression     

18

80

Both Male and Female

Interventional

Randomized

Placebo

Open label

Parallel

2008-10-20

135

Not Yet Recruiting

The proportion of patients with at least 50% improvement in the Chinese version of 13-item Beck Depression Inventory (BDI) score Percentage of patients with Hamilton Depression score (HAM-D) < or =7

The average change in BDI score at 6-month compared to that in baseline The improvement in health-related quality of life assessed by The Chinese (Hong Kong) SF-36 at baseline and 6-month The baseline and 6-month Clinical Global Impression-Severity of Illness (CGI-S) and Improvement (CGI-I) scales Percentage of patients who compliant with antidepressant treatment at 3- and 6-month. Patients who consumed >80% of pills dispensed during the prescribed period will be categorized as compliant with antidepressant treatment Cost-utility analyses to estimate the ratio between the cost of intervention and the potentialbenefit in symptom improvement observed

No

2012-06-28

ChiCTR-TRC-09000726

2010-05-04


Yes

Type Access Document Published On  
No documents yet.
  • Page 1 of 1.